Showing 11 posts of 11 posts found.


Roche’s Ocrevus more effective than Merck’s Rebif, company claims

September 14, 2016
Research and Development Merck, Ocrevus, Rebif, Roche, multiple sclerosis

Roche has announced new results from the Phase III studies of investigational medicine Ocrevus (ocrelizumab) studying relapsing multiple sclerosis (RMS) …

new Merck sign

Merck achieves 7% sales growth in Q3 2015

November 12, 2015
Sales and Marketing Merck, Rebif, financial results

German pharma group Merck has earned a 7% bump in its sales, and a 10% boost in earnings before deductions, …

Merck KGaA’s sales climb but key drugs fall

May 19, 2015
Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif

Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …

Biogen image

FDA approves Biogen’s long-acting MS drug

August 18, 2014
Sales and Marketing Avonex, Biogen, FDA, MS, Rebif, plegridy, tecfidera

Biogen Idec has racked up another approval over the weekend after its latest multiple sclerosis treatment Plegridy gained FDA backing. …

Aubagio image

Aubagio approved in Europe

September 3, 2013
Sales and Marketing Aubagio, Genzyme, Rebif, Sanofi, tecfidera

Sanofi’s once-daily multiple sclerosis pill Aubagio has been authorised by European regulators, paving the way for it to continue its …


Genzyme MS drug approved in US

September 13, 2012
Medical Communications Aubagio, Genzyme, Rebif, Sanofi, Tysabri, gilenya, multiple sclerosis

US regulators have given the green light for Genzyme’s Aubagio to treat patients with relapsing forms of multiple sclerosis (MS). …

Merck KGaA image

Merck KGaA manufacturing under scrutiny by FDA

March 27, 2012
Manufacturing and Production FDA, Merck KGaA, Rebif, Violations, manufacturing

The US Food and Drug Administration has asked Merck KGaA to undertake a ‘comprehensive and global assessment’ of its manufacturing …

Rebif image

Rebif approved for early use in MS

January 26, 2012
Sales and Marketing MS, Merck KGaA, Merck Serono, Rebif

The European Commission has approved an indication for multiple sclerosis treatment Rebif that treats early signs of the condition.This EC …

Sanofi’s Lemtrada beats Rebif in new study

November 14, 2011
Research and Development, Sales and Marketing Lemtrada, Rebif, Sanofi

Lemtrada has beaten Merck Serono’s multiple sclerosis treatment Rebif in a new head-to-head trial, paving the way for regulatory submission …

Blog footer

Digital Pharma: Merck Serono sets up MS social network

February 18, 2011
Medical Communications Digital Pharma blog, MS, Merck Serono, Movectro, Rebif, multiple sclerosis, social networking

Merck Serono has set up an international social network for multiple sclerosis patients, saying today’s pharma companies should go beyond …

Merck KGaA posts modest revenue increase

February 24, 2010
2009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif

German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth.  Revenues increased 2.1% to 7.7 …

Latest content